Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals submits copy of press release

19 May 2016 Evaluate

Glenmark Pharmaceuticals has submitted a copy of Press Release dated May 19, 2016 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Rufinamide Tablets USP, 200 mg and 400 mg’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..